Backer Marianne De Sells 79,712 Shares of Vir Biotechnology, Inc. (NASDAQ:VIR) Stock
CEO Backer Marianne De sold 79,712 shares of Vir Biotechnology stock in a transaction that occurred on Thursday, April 3rd. The shares were sold at an average price of $5.95, for a total value of $474 ...
The Independent9h
Tackling Africa’s vaccine supply and demand puzzle
How should continental vaccine manufacturers handle complex dynamics of supply and demand? ANALYSIS | The African Union has ...
Moderna to Showcase Extensive Infectious Disease Research at ESCMID 2025
Moderna, Inc. (NASDAQ:MRNA) today announced that the Company will present research across multiple infectious disease areas, including COVID-19, influenza, respiratory syncytial virus (RSV), ...
Healio5h
RSV may elevate risk for stroke, heart failure hospitalization
Acute respiratory syncytial virus was associated with elevated incidence of cardiovascular events among older adults, ...
Pulmonology Advisor3h
How Do Coinfections Influence Disease Severity, Progression in Pediatric Viral LRTIs?
Coinfection with RSV, REV, and MPV was significantly associated with treatment failure and prolonged treatment in children with viral LRTIs on respiratory support.
ModernaTX, Inc: Moderna to Showcase Extensive Infectious Disease Research at ESCMID 2025
CAMBRIDGE, MA / ACCESS Newswire / April 7, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the Company will present research across multiple infectious disease areas, including COVID-19, influ ...
HealthDay on MSN1h
Older Adults Have Low Knowledge of RSV Disease and Vaccine Eligibility
Knowledge of respiratory syncytial virus (RSV) disease and RSV vaccine eligibility is low among hospitalized older adu ...